A Plus Biotechnology , Ltd. Total Liabilities

As of the most recent data (March 2026), 6918.TWO shows a total liabilities of $540M. That compares with $380M in the prior-year period — up 42.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6918.TWO's total liabilities is now $540M (was $380M) — a 42.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether A Plus Biotechnology , Ltd. is outperforming or lagging.

Tracking 6918.TWO's total liabilities over time shows whether A Plus Biotechnology , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $540M That compares with $380M in the prior-year period — up 42.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has A Plus Biotechnology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $540M) with ownership activity and broader fundamentals.